Search PubMed⌕ Search

Biomedical subjects

N Schlackman

Publications and source records attributed to N Schlackman.

25 records · Page 2Linked to original sources
PubMed1991

The quality care cycle.

This paper describes an HMO--US Healthcare--which is based on a philosophy of quality-based managed health care. The paper shows how an individual patient interacts with the cycle of care in terms of risk evaluation, health education and prevention, diagnosis, treatment, referral, case management, and outcome. Other components of the cycle of care include primary certification and recertification of providers, criteria for procedure and site appropriateness, and evaluation of the professional qualifications of providers.

Clinical Competence↗
PubMed1975

Myelofibrosis in children with chronic renal insufficiency.

During investigation of splenomegaly in a boy with chronic renal failure and osteodystrophy, bone marrow aspirates resulted in "dry taps," whereas biopsied material provided evidence that the marrow had been replaced by fibrous tissue. In a study of six other children with chronic renal failure, similar changes were observed. These findings suggest that the anemia of chronic renal failure may in part be a result of myelofibrosis, and the resulting reduction of functional bone marrow may limit the tolerance to immunosuppressive agents in patients who undergo renal transplantation.

Adolescent↗
PubMed1975

Organophosphates--a pediatric hazard.

These agents act as anticholinesterases. Signs of toxicity are: overactivity of the parasympathetic nervous system, nausea, vomiting, diarrhea, sweating, abdominal cramps and copious secretions. Large doses may cause sustained depolarization of the motor end plate, leading to muscular paralysis. Death may ensue from respiratory failure. The extensive and often careless use of insecticides, fungicides and pesticides makes organophosphates a particular pediatric hazard. Atropine and pralidoxime chloride are effective for therapy.

Accidents↗
PubMedDate not supplied

Integration of quality assessment and physician incentives.

The ultimate challenge in dealing with any type of risk incentive system is to be able to integrate the quality of care and the cost of care into an equitable system and to monitor the system and detect either barriers to care or the withholding of appropriate services. We believe it is possible to do this and have based our incentive model upon this premise. At U.S. Healthcare, we have been successful in developing some measures of quality in the ambulatory setting and have tied the measurements to our payment mechanism.

Models, Theoretical↗